Stable medicine combination
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANJING CHIA TAI TIANQING PHARMA
- Publication Date
- 2013-06-05
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The present invention relates to a stable pharmaceutical composition, in particular to rosuvastatin calcium: bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[formazan A stable pharmaceutical composition of (methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt (as shown in formula I).
[0002]
[0003] Formula I Background technique
[0004] Rosuvastatin calcium is a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCoA reductase) inhibitor, which can be used in the treatment of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis It is better than other statins on the market in reducing low-density lipoprotein (LDL-C) and increasing high-density lipoprotein (HDL-C), and it is well tolerated and safe. For "super statin".
[0005] One disadvantage of rosuvastatin calcium is that it is easily degraded under certain circumstances, such as in a higher temperature or higher humidity environment, and th...